Learn about this condition, its impact, and our breakthrough treatment approach
Begin AssessmentAmblyopia, commonly known as "lazy eye," is a vision development disorder in which an eye fails to achieve normal visual acuity, even with prescription eyeglasses or contact lenses. It begins during infancy and early childhood, typically developing from birth up to approximately 7 years of age, when the visual system is still maturing.
In amblyopia, the brain favors one eye over the other, effectively suppressing the visual information from the weaker eye. Over time, the brain's preference for the stronger eye leads to a deterioration of vision in the weaker eye. If left untreated, amblyopia can result in permanent vision loss in the affected eye.
Amblyopia affects approximately 2-3% of the population and is one of the most common causes of vision loss in children.
There are several types of amblyopia, categorized by their underlying causes:
Amblyopia often has no obvious symptoms, making it difficult for parents to detect without a professional eye examination. However, some signs that may indicate amblyopia include:
In infants, possible signs include:
Primary Causes:
Risk Factors:
Early diagnosis of amblyopia is crucial for effective treatment. Comprehensive eye examinations for children should begin in infancy and continue regularly throughout childhood. Diagnosis typically involves:
The American Academy of Ophthalmology and the American Academy of Pediatrics recommend that children have their eyes examined at the following ages:
The primary goal of amblyopia treatment is to achieve the best possible vision in the weaker eye and to help both eyes work together properly. Traditional treatment approaches include:
The duration of treatment varies depending on the severity of amblyopia, the age of the child, and compliance with treatment. Early intervention generally yields better results. Traditional medical opinion has held that treatment is most effective when started before age 7, but recent research suggests that older children and even adults may benefit from certain treatments, though with generally reduced effectiveness.
Our approach to amblyopia goes beyond conventional treatments by incorporating innovative therapies aimed at neural plasticity and visual rehabilitation. We recognize that the brain's visual pathways retain some degree of plasticity even beyond childhood, allowing for vision improvement at various ages.
Our comprehensive protocol includes:
While conventional treatments mainly focus on children, our approach can potentially benefit adolescents and adults with amblyopia as well, though we emphasize that early intervention yields the best results.